Citation: | Pei Chen, Shiwen Wang, Bo Chen, Bing Lu, Xiaojing Zhang, Xiaohui Jiang, Yao Wang. High LIMP2 expression serves as a predictor for improved clinical outcomes in gastric cancer patients[J]. Blood&Genomics, 2020, 4(2): 142-150. doi: 10.46701/BG.2020022020119 |
[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
|
[2] |
Van Cutsem E, Sagaert X, Topal B. Haustermans kand prenen H gastric cancer[J]. Lancet, 2016, 388: 2654-2664. doi: 10.1016/S0140-6736(16)30354-3
|
[3] |
Allemani C, Weir HK, Carreira H, et al. Global surveil-lance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)[J]. Lancet, 2015, 385(9972): 977-1010. doi: 10.1016/S0140-6736(14)62038-9
|
[4] |
Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function[J]. Nat Rev Mol Cell Biol, 2009, 10(9): 623-635. http://www.nature.com/nrm/journal/v10/n9/fig_tab/nrm2745_F1.html
|
[5] |
Fujita H, Ezaki J, Noguchi Y, et al. Isolation and sequencing of a cDNA clone encoding 85kDa sialogly-coprotein in rat liver lysosomal membranes[J]. Biochem Biophys Res Commun, 1991, 178(2): 444-452. doi: 10.1016/0006-291X(91)90127-S
|
[6] |
Endemann G, Stanton LW, Madden KS, et al. CD36 is a receptor for oxidized low density lipoprotein[J]. J Biol Chem, 1993, 268(16): 11811-11816. doi: 10.1016/S0021-9258(19)50272-1
|
[7] |
Acton SL, Scherer PE, Lodish HF, et al. Expression cloning of SR-BI, a CD36-related class B scavenger receptor[J]. J Biol Chem, 1994, 269(33): 21003-21009. doi: 10.1016/S0021-9258(17)31921-X
|
[8] |
Reczek D, Schwake M, Schröder J, et al. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase[J]. Cell, 2007, 131(4): 770-783. doi: 10.1016/j.cell.2007.10.018
|
[9] |
Kampine JP, Brady RO, Kanfer JN, et al. Diagnosis of gaucher's disease and niemann-pick disease with small samples of venous blood[J]. Science, 1967, 155(3758): 86-88. doi: 10.1126/science.155.3758.86
|
[10] |
Tayebi N, Callahan M, Madike V, et al. Gaucher disease and parkinsonism: A phenotypic and genotypic characterization[J]. Mol Genet Metab, 2001, 73(4): 313-321. doi: 10.1006/mgme.2001.3201
|
[11] |
Aharon-Peretz J, Rosenbaum H Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews[J]. N Engl J Med, 2004, 351(19): 1972-7. doi: 10.1056/NEJMoa033277
|
[12] |
Yamayoshi S, Yamashita Y, Li J, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71[J]. Nat Med, 2009, 15(7): 798-801. doi: 10.1038/nm.1992
|
[13] |
Yamayoshi S, Iizuka S, Yamashita T, et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71[J]. J Virol, 2012, 86(10): 5686-5696. doi: 10.1128/JVI.00020-12
|
[14] |
Kuronita T, Eskelinen EL, Fujita H, et al. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology[J]. J Cell Sci, 2002, 115(Pt 21): 4117-4131. http://www.ncbi.nlm.nih.gov/pubmed/12356916
|
[15] |
Conrad KS, Cheng TW, Ysselstein D, et al. Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies[J]. Nat Commun, 2017, 8(1): 1908. doi: 10.1038/s41467-017-02044-8
|
[16] |
Berkovic SF, Dibbens LM, Oshlack A, et al. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis[J]. Am J Hum Genet, 2008, 82(3): 673-684. doi: 10.1016/j.ajhg.2007.12.019
|
[17] |
Gamp AC, Tanaka Y, Lüllmann-Rauch R, et al. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice[J]. Hum Mol Genet, 2003, 12(6): 631-646. doi: 10.1093/hmg/ddg062
|
[18] |
Johnson IR, Parkinson-Lawrence EJ, Shandala T, et al. Altered endosome biogenesis in prostate cancer has biomarker potential[J]. Mol Cancer Res, 2014, 12(12): 1851-1862. doi: 10.1158/1541-7786.MCR-14-0074
|
[19] |
Pasini FS, Maistro S, Snitcovsky I, et al. Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma[J]. Acta Oncol, 2012, 51(1): 77-85. doi: 10.3109/0284186X.2011.620619
|
[20] |
Chen P, Liu C, Li P, et al. High RhCG expression predicts poor survival and promotes migration and proliferation of gastric cancer via keeping intracellular alkaline[J]. Exp Cell Res, 2020, 386(2): 111740. doi: 10.1016/j.yexcr.2019.111740
|
[21] |
Sun MJ, Qi Y, Jin Q, et al. Increased SLC4A11 expression is associated with poor prognosis of gastric cancer[J]. Blood and Genomics, 2020, 4(1): 61-70. doi: 10.46701/BG.2020012019119
|
[22] |
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles[J]. Proc Natl Acad Sci U S A, 2005, 102(43): 15545-15550. doi: 10.1073/pnas.0506580102
|
[23] |
Li T, Fan J, Wang BB, et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res, 2017, 77(21): e108-e110. doi: 10.1158/0008-5472.CAN-17-0307
|
[24] |
Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 45(W1): W98-W102. doi: 10.1093/nar/gkx247
|
[25] |
Carrasco-Marín E, Fernández-Prieto L, Rodriguez-Del RE, et al. LIMP-2 links late phagosomal trafficking with the onset of the innate immune response to Listeria monocytogenes: a role in macrophage activation[J]. J Biol Chem, 2011, 286(5): 3332-3341. doi: 10.1074/jbc.M110.146761
|
[26] |
Savas P, Salgado R, Denkert C, et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic[J]. Nat Rev Clin Oncol, 2016, 13(4): 228-241. doi: 10.1038/nrclinonc.2015.215
|
[27] |
Kalkman HO, Feuerbach D. Antidepressant therapies inhibit inflammation and microglial M1-polarization[J]. Pharmacol Ther, 2016, 163: 82-93. doi: 10.1016/j.pharmthera.2016.04.001
|
[28] |
Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm[J]. Nat Immunol, 2010, 11(10): 889-896. doi: 10.1038/ni.1937
|
[29] |
Hardbower DM, Singh K, Asim M, et al. EGFR regu-lates macrophage activation and function in bacterial infection[J]. J Clin Invest, 2016, 126(9): 3296-3312. doi: 10.1172/JCI83585
|
[30] |
Zhao G, Liu L, Peek RJ, et al. Activation of epidermal growth factor receptor in macrophages mediates feedback inhibition of M2 polarization and gastrointestinal tumor cell growth[J]. J Biol Chem, 2016, 291(39): 20462-20472. doi: 10.1074/jbc.M116.750182
|